根据泛癌分析,NSUN6的表达与人类癌症的预后和免疫透相关
1Department of Respiratory Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
Scientific reports
|July 10, 2025
概括
这项研究表明,tRNA甲基化调节剂NSUN6基因与33种癌症类型的患者预后和免疫细胞透有关. 较高的NSUN6表达通常与各种癌症的改善生存结果相关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- NSUN6调节tRNA甲基化,影响tRNA的产生.
- 它在泛癌表达,预后和免疫入侵中的作用仍然未被研究.
- NSUN6在Golgi和中心体中局部存在.
研究的目的:
- 通过使用TCGA数据,研究33种癌症类型中NSUN6的表达模式.
- 分析NSUN6表达与患者预后,存活率和免疫细胞透之间的相关性.
- 探索NSUN6在各种癌症中的潜在诊断和预测价值.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库对33组癌症和正常组织进行分析.
- 进行表达分析,生存分析和基因组丰富分析 (GSEA).
- 与免疫和树皮细胞透和丰富途径相关的NSUN6表达.
主要成果:
- 在不同癌症类型中,NSUN6的表达有显著的变化,在8种癌症中增加 (例如肺腺癌,胰腺癌) 和6种癌症中减少 (例如胆管癌,甲状腺癌).
- 在一些癌症中,更高的NSUN6表达与改善的整体存活率,疾病特异性存活率和无进展间隔有关.
- NSUN6表达与免疫透相关,并被确定为脏清细胞癌和胰腺癌等特定癌症的潜在诊断指标.
结论:
- 在各种癌症中,NSUN6的表达显著改变,并且与患者的预后和免疫微环境有关.
- NSUN6可能作为一种潜在的生物标志物用于诊断和预测特定癌症类型的结果.
- 需要进一步的实验验证,以确认这些in silico发现.
相关概念视频
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer Survival Analysis
457
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
457
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K


